Lv1
45 积分 2021-12-15 加入
Phase I Study of Belantamab Mafodotin in Combination with Standard of Care in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Dreamm-9 Updated Interim Analysis
3小时前
求助中
A phase 1 study of belantamab mafodotin in combination with standard of care in newly diagnosed multiple myeloma: An interim analysis of DREAMM-9
3小时前
求助中
P-395 Updated Results From DREAMM-3, a Phase 3 Study of Belantamab Mafodotin (Belamaf) Versus Pomalidomide Plus Dexamethasone in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM)
9小时前
已完结
Recommendations for the diagnosis and management of lupus nephritis in China
2个月前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
5个月前
已完结
Breakthrough Hemolysis in PNH with Proximal or Terminal Complement Inhibition
5个月前
已完结
Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials
5个月前
已完结
Off-Label Uses of Omalizumab
5个月前
已完结
Treatment of acute urticaria: A systematic review
5个月前
已完结
Chronic Urticaria in Older Adults: Treatment Considerations
6个月前
已完结
皖公网安备34019202002308
